NASIS | פרסומים מדעיים בעיתונים רפואיים

NASIS Publications

 Ischemic Stroke on Awakening: Patients' Characteristics, Outcomes and Potential for Reperfusion Therapy. Neuroepidemiology 2012, In-press.

Stroke in very elderly: characteristics and predictors of outcome in patients aged ≥ 85 years with a first-ever ischemic stroke. Neuroepidemiology 2012, In-press.

Trends in Management and Outcome of Hospitalized Patients With Acute Stroke and Transient Ischemic Attack: The National Acute Stroke Israeli (NASIS) Registry. Stroke. 2012 [Epub ahead of print].

Off-hours admission for acute stroke is not associated with worse outcome–a nationwide Israeli stroke project. Eur J Neurol. 2012 Apr;19(4):643-7.

Ethnic variations in acute ischemic stroke: findings from the National Acute Stroke Israeli Survey (NASIS). Cerebrovasc Dis. 2011;31(5):506-10.

Anticoagulation remains underused in prevention of stroke associated with atrial fibrillation: insights from two consecutive national surveys. Int J Cardiol. 2011 Nov 3;152(3):356-61.

Derivation and validation of the prolonged length of stay score in acute stroke patients. Neurology. 2010 May 11;74(19):1511-6.

Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]). Am J Cardiol. 2010 Feb 1;105(3):411-6.

Mortality and predictors of death 1 month and 3 years after first-ever ischemic stroke: data from the first national acute stroke Israeli survey (NASIS 2004). Neuroepidemiology. 2010;34(2):90-6.

Prior use of statins improves outcome in patients with intracerebral hemorrhage: prospective data from the National Acute Stroke Israeli Surveys (NASIS). Stroke. 2009 Jul;40(7):2581-4.

Hospital disposition after stroke in a national survey of acute cerebrovascular diseases in Israel. Arch Phys Med Rehabil. 2008 Mar;89(3):435-40.

A national survey of acute cerebrovascular disease in Israel: burden, management, outcome and adherence to guidelines. Isr Med Assoc J. 2006 Jan;8(1):3-7.